In vivo MRS measurement of liver lipid levels in mice

Joel R. Garbow, Xing Lin, N. Sakata, Z. Chen, Deborah Koh, Gustav Schonfeld

Journal of Lipid Research · 2004 · 41 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

A magnetic resonance spectroscopy (MRS) procedure for in vivo measurement of lipid levels in mouse liver is described and validated. The method uses respiratory-gated, localized spectroscopy to collect proton spectra from voxels within the mouse liver. Bayesian probability theory analysis of these spectra allows the relative intensities of the lipid and water resonances within the liver to be accurately measured. All spectral data were corrected for measured spin-spin relaxation. A total of 48 mice were used in this study, including wild-type mice and two different transgenic mouse strains. Different groups of these mice were fed high-fat or low-fat diets or liquid diets with and without the addition of alcohol. Proton spectra were collected at baseline and, subsequently, every 4 weeks for up to 16 weeks. Immediately after the last MRS measurement, mice were killed and their livers analyzed for triglyceride level by conventional wet-chemistry methods. The excellent correlation between in vivo MRS and ex vivo wet-chemistry determinations of liver lipids validates the MRS method.These results clearly demonstrate that in vivo MRS will be an extremely valuable technique for longitudinal studies aimed at providing important insights into the genetic, environmental, and dietary factors affecting fat deposition and accumulation within the mouse liver. A magnetic resonance spectroscopy (MRS) procedure for in vivo measurement of lipid levels in mouse liver is described and validated. The method uses respiratory-gated, localized spectroscopy to collect proton spectra from voxels within the mouse liver. Bayesian probability theory analysis of these spectra allows the relative intensities of the lipid and water resonances within the liver to be accurately measured. All spectral data were corrected for measured spin-spin relaxation. A total of 48 mice were used in this study, including wild-type mice and two different transgenic mouse strains. Different groups of these mice were fed high-fat or low-fat diets or liquid diets with and without the addition of alcohol. Proton spectra were collected at baseline and, subsequently, every 4 weeks for up to 16 weeks. Immediately after the last MRS measurement, mice were killed and their livers analyzed for triglyceride level by conventional wet-chemistry methods. The excellent correlation between in vivo MRS and ex vivo wet-chemistry determinations of liver lipids validates the MRS method. These results clearly demonstrate that in vivo MRS will be an extremely valuable technique for longitudinal studies aimed at providing important insights into the genetic, environmental, and dietary factors affecting fat deposition and accumulation within the mouse liver. Alcoholic (1Maher J. Alcoholic steatosis and steatohepatitis.Semin. Gastrointest. Dis. 2002; 13: 31-39Google Scholar, 2Lieber C. New concepts of the pathogenesis of alcoholic liver disease.Curr. Gastroenterol. Rep. 2004; 6: 60-65Google Scholar) and nonalcoholic fatty liver (NAFL) (3Angulo P. Nonalcoholic fatty liver disease.N. Engl. J. Med. 2002; 346: 1221-1231Google Scholar, 4Teli M.R. James O.F. Burt A.D. Bennett M.K. Day C.P. The natural history of nonalcoholic fatty liver: a follow-up study.Hepatology. 1995; 22: 1714-1719Google Scholar, 5Matteoni C.A. Younossi Z.M. Gramlich T. Boparai N. Liu Y.C. McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.Gastroenterology. 1999; 116: 1413-1419Google Scholar, 6Marchesini G. Bugianesi E. Forlani G. Cerrelli F. Lenzi M. Manini R. Natale S. Vanni E. Villanova N. Melchionda N. Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.Hepatology. 2003; 37: 917-923Google Scholar, 7Powell E.E. Cooksley W.G. Hanson R. Searle J. Halliday J.W. Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.Hepatology. 1990; 11: 74-80Google Scholar) are highly prevalent in human populations and may develop into steatohepatitis and in some cases into cirrhosis requiring liver transplantation. Animal models of both conditions have been developed. Mouse models are particularly useful because genetic manipulations are highly developed in inbred mice. However, longitudinal studies require the killing of animals because no noninvasive method for quantifying liver fat is available. Here, we describe a noninvasive, nondestructive method for quantifying the liver fat contents of the mouse using a NAFL mouse model. The overwhelming majority of NAFL cases are associated with obesity, dyslipidemia, hypertension, insulin-resistant type 2 diabetes mellitus, and atherosclerotic cardiovascular disease (8Ikai E. Ishizaki M. Suzuki Y. Ishida M. Noborizaka Y. Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people.J. Hum. Hypertens. 1995; 9: 101-105Google Scholar, 9Seppala-Lindroos A. Vehkavaara S. Hakkinen A.M. Goto T. Westerbacka J. Sovijarvi A. Halavaara J. Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.J. Clin. Endocrinol. Metab. 2002; 87: 3023-3028Google Scholar, 10Zavaroni I. Mazza S. Dall'Aglio E. Gasparini P. Passeri M. Reaven G.M. Prevalence of hyperinsulinaemia in patients with high blood pressure.J. Intern. Med. 1992; 231: 235-240Google Scholar, 11Lakka H.M. Laaksonen D.E. Lakka T.A. Niskanen L.K. Kumpusalo E. Tuomilehto J. Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.J. Am. Med. Assoc. 2002; 288: 2709-2716Google Scholar, 12Marchesini G. Brizi M. Morselli-Labate A.M. Bianchi G. Bugianesi E. McCullough A.J. Forlani G. Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance.Am. J. Med. 1999; 107: 450-455Google Scholar). This constellation defines the metabolic syndrome (13Reaven G.M. Banting Lecture 1988. Role of insulin resistance in human disease.Diabetes. 1988; 37: 1595-1607Google Scholar, 14Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease.Circulation. 2002; 106: 286-288Google Scholar). One naturally occurring cause of fatty liver is familial hypobetalipoproteinemia (FHBL). FHBL is defined by less than fifth percentile plasma levels of LDL-cholesterol and/or total apolipoprotein B (apoB), segregating in families as an autosomal dominant trait (15Linton M.F. Farese Jr., R.V. Young S.G. Familial hypobetalipoproteinemia.J. Lipid Res. 1993; 34: 521-541Google Scholar, 16Schonfeld G. The hypobetalipoproteinemias.Annu. Rev. Nutr. 1995; 15: 23-34Google Scholar, 17Schonfeld G. Familial hypobetalipoproteinemia: a review.J. Lipid Res. 2003; 44: 878-883Google Scholar). The mean liver triglyceride content in apoB-impaired FHBL subjects is 3- to 5-fold greater than that of controls (18Schonfeld G. Patterson B.W. Yablonskiy D.A. Tanoli T.S. Averna M. Elias N. Yue P. Ackerman J. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.J. Lipid Res. 2003; 44: 470-478Google Scholar, 19Homanics G.E. Smith T.J. Zhang S.H. Lee D. Young S.G. Maeda N. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice.Proc. Natl. Acad. Sci. USA. 1993; 90: 2389-2393Google Scholar). In an attempt to understand the cellular/molecular bases of hypobetalipoproteinemia, several recombinant mice mimicking human FHBL have been produced (19Homanics G.E. Smith T.J. Zhang S.H. Lee D. Young S.G. Maeda N. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice.Proc. Natl. Acad. Sci. USA. 1993; 90: 2389-2393Google Scholar, 20Srivastava R.A. Toth L. Srivastava N. Hinsdale M.E. Maeda N. Cefalu A.B. Averna M. Schonfeld G. Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB.Mol. Cell. Biochem. 1999; 202: 37-46Google Scholar, 21Kim E. Cham C.M. Veniant M.M. Ambroziak P. Young S.G. Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the apoB gene.J. Clin. Invest. 1998; 101: 1468-1477Google Scholar, 22Kim E. Ambroziak P. Veniant M.M. Hamilton R.L. Young S.G. A gene-targeted mouse model for familial hypobetalipoproteinemia. Low levels of apolipoprotein B mRNA in association with a nonsense mutation in exon 26 of the apolipoprotein B gene.J. Biol. Chem. 1998; 273: 33977-33984Google Scholar, 23Chen Z. Fitzgerald R.L. Averna M.R. Schonfeld G. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.J. Biol. Chem. 2000; 275: 32807-32815Google Scholar, 24Chen Z. Fitzgerald R.L. Schonfeld G. Hypobetalipoproteinemic mice with a targeted apolipoprotein (apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254–1744 of apoB in lipid transport and metabolism of the apoB-containing lipoprotein.J. Biol. Chem. 2002; 277: 14135-14145Google Scholar, 25Chen Z. Fitzgerald R.L. Li G. Davidson N.O. Schonfeld G. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.J. Lipid Res. 2004; 45: 155-163Google Scholar). The resulting mice closely resemble their human counterparts with respect to the fatty liver phenotype. Thus, these mice could serve as good models of one genetic form of fatty liver for studies of the progression of fatty liver and on the effects of metabolic, hormonal, and therapeutic perturbations over time. One current limitation of such studies is the absence of an accurate, quantifiable, noninvasive method for repeat assessments of liver fat in animals. In humans, the gold standard for quantifying liver fat is the liver biopsy, which is invasive and, at best, semiquantitative. The analogous procedure in animals is killing of the animal and direct analysis of liver fat by standard chemical methods after extraction. Obviously, direct sampling of livers for fat analysis is not ideal for longitudinal, follow-up studies in humans or animals. Noninvasive methods would be preferable in humans; these include ultrasound and computed tomography scanning with use of brightness scales (26Siegelman E. Rosen M. Imaging of hepatic steatosis.Semin. Liver Dis. 2001; 21: 71-80Google Scholar). However, although these methods are noninvasive, they are not based on lipid chemical determinants. Furthermore, these methods have not been adapted to mice. Proton magnetic resonance spectroscopy (MRS) is a powerful and versatile analytical technique that is specific, noninvasive, and quantitative. As a consequence, MRS is well suited for in vivo, longitudinal studies of liver lipids in rodents. Proton MRS methods have been used widely to characterize triacylglycerols and other fatty acids in tissue and tissue extracts (27Marcel S. Lie K. Lam C. 1H-nuclear magnetic resonance spectroscopic studies of saturated, acetylenic and ethylenic triacylglycerols.Chem. Phys. Lipids. 1995; 77: 155-171Google Scholar, 28Waters N. Garrod S. Farrant R. Haselden J. Connor S. Connelly J. Lindon J. Holmes E. Nicholson J. High-resolution magic angle spinning 1H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition.Anal. Biochem. 2000; 282: 16-23Google Scholar, 29Waters N. Holmes E. Waterfield C. Farrant R. Nicholson J. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with α-naphthylisothiocyanate.Biochem. Pharmacol. 2002; 64: 67-77Google Scholar, 30Sathasivam N. Brammah S. of lipid accumulation in human by 2003; and MRS studies of liver lipids in humans have been described (18Schonfeld G. Patterson B.W. Yablonskiy D.A. Tanoli T.S. Averna M. Elias N. Yue P. Ackerman J. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.J. Lipid Res. 2003; 44: 470-478Google Scholar, C. K. P. M. of liver fat using magnetic resonance Scholar, R. P. C. F. L. L. P. S. C. L. Proton spectroscopy in in vivo of fat content in human liver steatosis.J. 1995; Scholar, C. R. E. M. P. F. L. S. C. L. Noninvasive in vivo of fat content in human Scholar, E.E. F. R.L. A. of triglyceride by in J. 1999; Scholar). MRS of liver fat levels in rats have been P. K. A. D. C. J. J. D. R. liver lipid in I. 1H MRS study Med. 2001; Scholar, N. J. P. J. of hepatic steatosis, and of by studies in fatty Metab. 2003; Scholar). However, the of transgenic and the between mouse and human the mouse for a of than is the The of the mouse liver mouse the of a a in the of MRS The of this to MRS to in vivo measurement of liver fat in mice. on the and of this and on in longitudinal studies in mouse models of FHBL from of The results that the method may be to studies of liver fat in other mouse models of fatty liver, including fatty liver by alcohol. and spectra of mice were collected in an with The are with a NMR and data were collected using a were with and during the and spectroscopy respiratory-gated, were collected with a between and proton spectroscopy data were collected using both spectroscopy in NMR spectroscopy in N. Y. Acad. Sci. Scholar) and by M. L. The of the for 2001; Scholar). use a of magnetic and angle to a of and spectrum is collected and The method uses A. M. Scholar). These the less to effects M. L. The of the for 2001; the stability and of the measured liver As a of the spectroscopy data were collected with that be into the in in of the As a consequence, the in these is the measurement of liver lipid levels in we voxels that were 4 4 This after is that spectra of voxels have are to be within the mouse liver. Bayesian probability theory methods have been described for the analysis of magnetic resonance data J. G. the use of Bayesian probability theory for analysis of an from Med. 1993; Scholar, Ackerman of and Bayesian analysis of NMR I. resonances 1992; Scholar, Ackerman of and Bayesian analysis of of truncated free NMR A. 1995; 116: Scholar). spectral allows of the data and of the spectral Here, we use both to model the localized proton spectra of liver, of relative lipid and to spin-spin from is a analysis data as the of The and of in the spectrum are with an for of these this the important were the relative of the water and lipid in of the water and lipid as a of were and these were to an a using methods. All animal procedures were in with the of Animal of two different a total of 48 are different of transgenic and have been developed to the role of apoB in fatty transport and fat accumulation in liver. In a targeted mutation causes fatty livers as a of the reduced ability of to transport Z. Fitzgerald R.L. Averna M.R. Schonfeld G. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.J. Biol. Chem. 2000; 275: 32807-32815Google Scholar). Hypobetalipoproteinemic mice with a targeted mutation demonstrate reduced to transport and apoB-containing Z. Fitzgerald R.L. Schonfeld G. Hypobetalipoproteinemic mice with a targeted apolipoprotein (apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254–1744 of apoB in lipid transport and metabolism of the apoB-containing lipoprotein.J. Biol. Chem. 2002; 277: 14135-14145Google Scholar). of these wild-type were in these The mice and controls were fed high-fat or low-fat diets for with spectroscopic data collected every 4 weeks. the mice and controls were fed a liquid with or without the addition of alcohol The use of wild-type and transgenic with and alcohol produced mice with liver lipids from to to and the MRS method over a of All diets were from a of The and low-fat diets were both in the form of the low-fat from and and The for the high-fat were and The liquid from a with and with In this liquid the of the total The alcohol from this liquid by content and that the alcohol of the in the animals were fed the liquid without for the of baseline measured and the mice were to their Immediately after the last MRS measurement, mouse killed and liver and in liquid were from liver as described A method of total lipid and J. Biochem. 37: Scholar). The lipid extracts were in in a of and in water of free and total in tissue lipid Biochem. 1993; Scholar). A used for the of The hepatic triglyceride as of of content using the in vivo localized proton spectra from the livers of two different one low lipid content and the other lipid content The on the spectrum a of the The spectra are by the water at resonances in these spectra are to liver with the at from fatty the an of the proton of a in vivo spectrum of high-fat liver. In addition to the other lipid be to and from groups to or in the lipid 2 the resonances in this proton using ability to accurately model these accurately in the of baseline J. G. the use of Bayesian probability theory for analysis of an from Med. 1993; Scholar, Ackerman of and Bayesian analysis of NMR I. resonances 1992; Scholar, Ackerman of and Bayesian analysis of of truncated free NMR A. 1995; 116: Scholar). As a consequence, we of the proton and not the in the lipid content of the liver. on localized proton of the relative intensities of lipid and water In several of the proton an to of the water at a chemical of In the liver lipid content by the of of these lipid including the resonance at were and with the of the water of the proton from an in vivo localized proton spectrum of a high lipid level liver. 1H of the Bayesian probability theory of the of at high and in spectral and in localized spectra J. J. M. A for or in and MRS in 2004; Scholar). of liver lipid levels spectroscopy the use of for the of both the for in the liver and the localized proton spectra from within the of mouse liver from collected with and without The collected without clearly from to This which is in the the with which voxels within the liver be is important for localized proton spectra with and in vivo localized spectra from a 4 4 within a mouse liver collected using the The of the from of the liver not The 1H spectra in which data with and the a of spectra in the absence of The effects of on spectral and clearly in the are by in vivo 1H spectra of mouse liver. spectra in which data with spectra in the absence of The dominant in these spectra is the water resonance at All data were collected from the 4 4 within the liver. 2 As described a to the of lipid levels is the of the spectroscopy within the liver. the of the MRS measurement, the on and of the liver, we an that results from several voxels within the liver. and MRS methods are from blood in within the liver not to of the liver or the resulting localized In standard MRS we collect respiratory-gated, of the liver. this of we that are clearly within the liver, as in a 4 4 within the of these the of the liver, and collect localized proton data for this The 4 4 of the in the resulting proton spectra within the liver. this a of to include the to the and in this the liver, in MRS data at we data from to voxels for on the and of the liver. we the data for using the relative lipid and water measured in the in measured lipid and water content the of voxels is less than of the resulting The proton spectra in were collected with a of this to both lipid and water as a of the effects of of relative lipid content for in between the lipid and water in liver. this for liver lipid measurement we collected a of with from to in the in which we measured spectra for a of the measurement for liver on a the of the of lipid and water resonances were by analysis of the proton and these spectral as a of were to using Bayesian methods. In the of the total lipid and not of spectral were measured and the measured are of the that the lipid in this were to measured total lipid to for the effects of relaxation. data for water and lipid intensities measured in a of with to the not in In we no correlation between measured and liver lipid no between and of mouse wild-type transgenic and no correlation between lipid and water for a total of are and The of to is a of is the measured in a with and is the of the at The are the of lipid and water measured at were by to for relaxation. This to the data on a mouse using the lipid and water for MRS measurement, we the of the lipid lipid to the of the lipid water to lipid within the liver. that liver lipid is a of different fatty of different and of However, of these fatty acids are of the lipid repeat of and Thus, the of total to is for of these fatty that lipid proton is a of total lipid within the liver. All of the spectra in this were collected with a of of on and from animal to on a of mice that with we the lipid content in liver by a of and we have of the results no study we no that in liver or with lipid content or of mouse transgenic This would be based on the data In is to in tissue and than Thus, the absence of in with lipid level or mouse for liver lipid levels for animal were measured at the of the study, and levels were measured at 4 up to or weeks or Immediately after the last MRS measurement, mouse killed and liver and in liquid liver, triglyceride levels were in using standard as described in The measurement is a method for triglyceride levels in tissue a triglyceride analysis lipid by MRS for 48 mice in this As described the MRS data were corrected on a animal for the effects of The correlation of the of this 2 the excellent correlation between the in vivo and ex vivo methods and to the magnetic resonance method. and are to of the animals in this study, the correlation of the of lipid levels by MRS and methods is the 2 with the that no in were in these animals. The of this in lipid levels measured MRS and for which a correlation the of The localized MRS technique described could be to the liver lipid content in mice in a to that in a study of triglyceride in human and liver and E.E. F. R.L. A. of triglyceride by in J. 1999; Scholar). As described in the a of this is to develop in vivo MRS methods to the longitudinal study of liver lipid levels in mice. with the of transgenic animal these will important insights into the genetic, environmental, and dietary factors affecting fat deposition and accumulation within the liver. the of such In the we the liver lipid as a of for mice fed and low-fat the lipid level in the livers of mice fed a high-fat is that of the animals on the low-fat the the liver lipid as a of for transgenic and wild-type fed the high-fat the liver lipid level of the mice is that of the wild-type animals. in both of these were analyzed using an with at powerful of these in vivo MRS is the of animals the of a have than two in liver lipid levels groups of mice not The ability to baseline lipid levels will the of aimed at the factors affecting liver fat deposition and the from these studies and the of animals This by of and a of Animal Imaging and The and

References

39